More Rite Aid pharmacies will be closing soon, including three newly revealed stores in New Hampshire.. Nationwide drugstore chain Rite Aid has filed for bankruptcy again, over one year after ...

An international clinical trial shows an innovative CAR-T cell immunotherapy is promising against aggressive T cell cancers and has manageable side effects. A new type of immunotherapy that ...

Nike expands its GT Cut 3 Turbo lineup with the introduction of the “Honeydew” colorway, blending performance-driven innovation with a refreshing aesthetic.

Candid's T-cell engager shopping spree rolls on with WuXi Biologics pact worth up to $925M As for Juri, very little is publicly known about the TCG Labs Soleil-created company.

More information: Yating Zheng et al, An engineered viral protein activates STAT5 to prevent T cell suppression, Science Immunology (2025). DOI: 10.1126/sciimmunol.adn9633 Journal information ...

The sarcasm didn’t stop there. “Aqua Line 3: It’s not just a name anymore. Underwater scenic route!” joked another, summing up the bizarre situation with a touch of humour. However ...

Cellares, in collaboration with Mitsui Fudosan, will establish Japan’s first next-gen commercial production site for CAR-T cell therapies. The facility is under construction in Kashiwa City.

In contrast, universal CAR-T cell therapies can be made ahead of time, stored frozen and be readily available "off-the-shelf," greatly reducing the wait time before therapy can begin.

Claudin 18 isoform 2–targeted chimeric antigen receptor T-cell therapy significantly prolongs time to disease progression in patients with refractory gastric or gastroesophageal junction cancer.